Clinical Trial Update: Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

View source ↗

Summary

A completed clinical trial evaluating second-line therapies for adults with type 2 diabetes mellitus and moderate cardiovascular disease risk. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes, Cardiac Disease | Status: COMPLETED | Results posted: 2025-10-10